Texas Instruments (TXN) 10-Q25 Oct 232023 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2023	Oct. 17, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-03761
Entity Registrant Name	TEXAS INSTRUMENTS INCORPORATED
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-0289970
Entity Address, Address Line One	12500 TI Boulevard
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75243
City Area Code	214
Local Phone Number	479-3773
Title of 12(b) Security	Common Stock, par value $1.00
Trading Symbol	TXN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		908,204,093
Entity Central Index Key	0000097476
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 4,532	$ 5,241	$ 13,442	$ 15,358
Cost of revenue (COR)	1,717	1,624	4,854	4,674
Gross profit	2,815	3,617	8,588	10,684
Research and development (R&D)	471	431	1,403	1,236
Selling, general and administrative (SG&A)	452	431	1,387	1,275
Restructuring charges/other	0	77	0	209
Operating profit	1,892	2,678	5,798	7,964
Other income (expense), net (OI&E)	128	33	327	55
Interest and debt expense	98	53	255	154
Income before income taxes	1,922	2,658	5,870	7,865
Provision for income taxes	213	363	731	1,078
Net income	$ 1,709	$ 2,295	$ 5,139	$ 6,787
Earnings per common share (EPS):
Basic (in dollars per share)	$ 1.87	$ 2.50	$ 5.63	$ 7.35
Diluted (in dollars per share)	$ 1.85	$ 2.47	$ 5.58	$ 7.27
Average shares outstanding:
Basic (in shares)	908	913	908	919
Diluted (in shares)	916	923	916	929
Diluted EPS:
Net income	$ 1,709	$ 2,295	$ 5,139	$ 6,787
Income allocated to RSUs	(10)	(11)	(26)	(30)
Income allocated to common stock for diluted EPS	$ 1,699	$ 2,284	$ 5,113	$ 6,757

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 1,709	$ 2,295	$ 5,139	$ 6,787
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($3) and ($4); ($4) and $2	6	11	6	(23)
Recognized within net income, net of tax effect of ($1) and ($4); ($3) and ($9)	3	15	9	33
Prior service cost (credit) of defined benefit plans:
Adjustments, net of tax effect of $0 and $0; $0 and $0	0	1	0	1
Recognized within net income, net of tax effect of $0 and $0; $0 and $0	1	(1)	1	(1)
Derivative instruments:
Change in fair value, net of tax effect of $0 and $0; $0 and $0	0	1	1	1
Available-for-sale investments:
Unrealized gains (losses), net of tax effect of $0 and $0; $0 and $2	1	(1)	2	(8)
Other comprehensive income (loss), net of taxes	11	26	19	3
Total comprehensive income	$ 1,720	$ 2,321	$ 5,158	$ 6,790

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net actuarial losses of defined benefit plans adjustment, tax effect	$ (3)	$ (4)	$ (4)	$ 2
Net actuarial losses of defined benefit plans recognized within net income, tax effect	(1)	(4)	(3)	(9)
Prior service credit of defined benefit plans adjustments, tax effect	0	0	0	0
Prior service credit of defined benefit plans recognized within net income, tax effect	0	0	0	0
Derivative instruments change in fair value, tax effect	0	0	0	0
Available-for-sale investments unrealized losses, tax effect	$ 0	$ 0	$ 0	$ 2

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,566	$ 3,050
Short-term investments	6,382	6,017
Accounts receivable, net of allowances of ($15) and ($13)	1,976	1,895
Raw materials	401	353
Work in process	2,147	1,546
Finished goods	1,360	858
Inventories	3,908	2,757
Prepaid expenses and other current assets	265	302
Total current assets	15,097	14,021
Property, plant and equipment at cost	12,528	9,950
Accumulated depreciation	(3,208)	(3,074)
Property, plant and equipment	9,320	6,876
Goodwill	4,362	4,362
Deferred tax assets	632	473
Capitalized software licenses	138	152
Overfunded retirement plans	166	188
Other long-term assets	1,923	1,135
Total assets	31,638	27,207
Current liabilities:
Current portion of long-term debt	300	500
Accounts payable	713	851
Accrued compensation	707	799
Income taxes payable	108	189
Accrued expenses and other liabilities	824	646
Total current liabilities	2,652	2,985
Long-term debt	10,922	8,235
Underfunded retirement plans	141	118
Deferred tax liabilities	66	66
Other long-term liabilities	1,226	1,226
Total liabilities	15,007	12,630
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued	0	0
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741	1,741	1,741
Paid-in capital	3,280	2,951
Retained earnings	52,098	50,353
Treasury common stock at cost: Shares: September 30, 2023 - 833; December 31, 2022 – 835	(40,253)	(40,214)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(235)	(254)
Total stockholders’ equity	16,631	14,577
Total liabilities and stockholders’ equity	$ 31,638	$ 27,207

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Allowance for doubtful accounts receivable, current	$ (15)	$ (13)
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10	10
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400	2,400
Common stock, shares issued (in shares)	1,741	1,741
Treasury stock (in shares)	833	835

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net income	$ 5,139	$ 6,787
Adjustments to net income:
Depreciation	853	676
Amortization of capitalized software	48	40
Stock compensation	294	227
Gains on sales of assets	(1)	(3)
Deferred taxes	(159)	(18)
Increase (decrease) from changes in:
Accounts receivable	(81)	(339)
Inventories	(1,151)	(494)
Prepaid expenses and other current assets	38	45
Accounts payable and accrued expenses	(23)	72
Accrued compensation	(97)	(114)
Income taxes payable	(65)	26
Changes in funded status of retirement plans	49	126
Other	(348)	(353)
Cash flows from operating activities	4,496	6,678
Cash flows from investing activities
Capital expenditures	(3,923)	(1,830)
Proceeds from asset sales	3	3
Purchases of short-term investments	(10,140)	(10,795)
Proceeds from short-term investments	9,976	10,007
Other	33	59
Cash flows from investing activities	(4,051)	(2,556)
Cash flows from financing activities
Proceeds from issuance of long-term debt	3,000	695
Repayment of debt	(500)	(500)
Dividends paid	(3,376)	(3,174)
Stock repurchases	(228)	(2,767)
Proceeds from common stock transactions	218	191
Other	(43)	(29)
Cash flows from financing activities	(929)	(5,584)
Net change in cash and cash equivalents	(484)	(1,462)
Cash and cash equivalents at beginning of period	3,050	4,631
Cash and cash equivalents at end of period	$ 2,566	$ 3,169

Description of business, includ

Description of business, including segment and geographic area information	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Description of business, including segment and geographic area information	Description of business, including segment and geographic area information We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels. Our segments also reflect how management allocates resources and measures results. • Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain. • Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application. We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP ® products, calculators and custom ASIC products. Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided. Segment information For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Revenue: Analog $ 3,353 $ 3,993 $ 9,920 $ 11,801 Embedded Processing 890 821 2,616 2,424 Other 289 427 906 1,133 Total revenue $ 4,532 $ 5,241 $ 13,442 $ 15,358 Operating profit: Analog $ 1,504 $ 2,185 $ 4,541 $ 6,561 Embedded Processing 258 321 813 960 Other (a) 130 172 444 443 Total operating profit $ 1,892 $ 2,678 $ 5,798 $ 7,964 (a) Includes restructuring charges/other Geographic area information The following geographic area information is based on product shipment destination, which does not reflect end demand by geography. For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Revenue: United States $ 630 14 % $ 694 13 % $ 1,900 14 % $ 1,765 11 % China (a) 1,880 41 2,441 47 5,531 41 7,740 50 Rest of Asia 571 13 694 13 1,654 12 1,993 13 Europe, Middle East and Africa 952 21 942 18 2,894 22 2,578 17 Japan 338 7 310 6 976 7 849 6 Rest of world 161 4 160 3 487 4 433 3 Total revenue $ 4,532 100 % $ 5,241 100 % $ 13,442 100 % $ 15,358 100 % (a) Revenue from products shipped into China includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries. The following additional geographic information includes our estimate for revenue based on the location of our end customers’ headquarters, providing a better representation of the geographic profile for where critical decisions are made. For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Revenue: United States $ 1,541 34 % $ 1,782 34 % $ 4,391 33 % $ 5,058 33 % China 813 18 1,143 22 2,561 19 3,758 24 Rest of Asia 434 10 534 10 1,263 10 1,643 11 Europe, Middle East and Africa (a) 1,193 26 1,281 24 3,657 27 3,480 23 Japan 455 10 446 9 1,373 10 1,252 8 Rest of world 96 2 55 1 197 1 167 1 Total revenue $ 4,532 100 % $ 5,241 100 % $ 13,442 100 % $ 15,358 100 % (a) Revenue from end customers headquartered in Germany was 13% and 11% in the third quarters of 2023 and 2022, respectively, and 13% and 10% in the first nine months of 2023 and 2022, respectively.

Basis of presentation and signi

Basis of presentation and significant accounting policies and practices	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and significant accounting policies and practices	Basis of presentation and significant accounting policies and practices Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2022. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2023 and 2022, and the Consolidated Balance Sheet as of September 30, 2023, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2022. The results for the three- and nine-month periods are not necessarily indicative of a full year’s results. Significant accounting policies and practices Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock. Computation and reconciliation of earnings per common share are as follows: For Three Months Ended September 30, 2023 2022 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 1,709 $ 2,295 Income allocated to RSUs (9) (11) Income allocated to common stock $ 1,700 908 $ 1.87 $ 2,284 913 $ 2.50 Dilutive effect of stock compensation plans 8 10 Diluted EPS: Net income $ 1,709 $ 2,295 Income allocated to RSUs (10) (11) Income allocated to common stock $ 1,699 916 $ 1.85 $ 2,284 923 $ 2.47 For Nine Months Ended September 30, 2023 2022 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 5,139 $ 6,787 Income allocated to RSUs (27) (30) Income allocated to common stock $ 5,112 908 $ 5.63 $ 6,757 919 $ 7.35 Dilutive effect of stock compensation plans 8 10 Diluted EPS: Net income $ 5,139 $ 6,787 Income allocated to RSUs (26) (30) Income allocated to common stock $ 5,113 916 $ 5.58 $ 6,757 929 $ 7.27 Potentially dilutive securities representing 9 million and 6 million shares of common stock that were outstanding during the third quarters of 2023 and 2022, respectively, and 9 million and 5 million shares outstanding during the first nine months of 2023 and 2022, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive. Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes. Fair values of financial instruments The fair values of our derivative financial instruments were not material as of September 30, 2023. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of September 30, 2023, the carrying value of long-term debt, including the current portion, was $11.22 billion, and the estimated fair value was $9.82 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.

Income taxes

Income taxes	9 Months Ended
Income taxes	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income taxes	Income taxes Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Taxes calculated using the estimated annual effective tax rate $ 229 $ 391 $ 794 $ 1,147 Discrete tax items (16) (28) (63) (69) Provision for income taxes $ 213 $ 363 $ 731 $ 1,078 Effective tax rate 11 % 14 % 12 % 14 % The effective tax rate differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits.

Valuation of debt and equity in

Valuation of debt and equity investments and certain liabilities	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Valuation of debt and equity investments and certain liabilities	Valuation of debt and equity investments and certain liabilities Investments measured at fair value Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. We classify all debt investments as available-for-sale. See Fair-value considerations . Unrealized gains and losses are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable investments are recognized in OI&E. Details of our investments are as follows: September 30, 2023 December 31, 2022 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Money market funds $ 1,141 $ — $ — $ 1,238 $ — $ — Corporate obligations 280 1,519 — 276 1,535 — U.S. government and agency securities 398 4,467 — 680 4,234 — Non-U.S. government and agency securities 100 396 — 149 248 — Mutual funds — — 11 — — 11 Total 1,919 6,382 11 2,343 6,017 11 Other measurement basis: Equity-method investments — — 16 — — 18 Non-marketable investments — — 5 — — 5 Cash on hand 647 — — 707 — — Total $ 2,566 $ 6,382 $ 32 $ 3,050 $ 6,017 $ 34 As of September 30, 2023, and December 31, 2022, unrealized gains and losses associated with our debt investments were not material. We did not recognize any credit losses related to debt investments for the first nine months of 2023 and 2022. The following table presents the aggregate maturities of our available-for-sale debt investments as of September 30, 2023: Fair Value One year or less $ 6,775 One to two years 385 Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.89 billion and $3.03 billion for the third quarters of 2023 and 2022, respectively, and $9.98 billion and $10.01 billion for the first nine months of 2023 and 2022, respectively. Gross realized gains and losses from these sales were not material. Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of September 30, 2023, and December 31, 2022, we had no Level 3 assets or liabilities. The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2023 December 31, 2022 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 1,141 $ — $ 1,141 $ 1,238 $ — $ 1,238 Corporate obligations — 1,799 1,799 — 1,811 1,811 U.S. government and agency securities 4,161 704 4,865 4,914 — 4,914 Non-U.S. government and agency securities — 496 496 — 397 397 Mutual funds 11 — 11 11 — 11 Total assets $ 5,313 $ 2,999 $ 8,312 $ 6,163 $ 2,208 $ 8,371 Liabilities: Deferred compensation $ 352 $ — $ 352 $ 326 $ — $ 326 Total liabilities $ 352 $ — $ 352 $ 326 $ — $ 326

Postretirement benefit plans

Postretirement benefit plans	9 Months Ended
Postretirement benefit plans	Sep. 30, 2023
Retirement Benefits [Abstract]
Postretirement benefit plans	Postretirement benefit plans Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2023 2022 2023 2022 2023 2022 Service cost $ 2 $ 4 $ — $ 1 $ 4 $ 6 Interest cost 7 8 4 3 14 7 Expected return on plan assets (6) (6) (4) (3) (16) (15) Recognized net actuarial losses (gains) 2 1 (1) — 3 1 Amortization of prior service cost (credit) — — — (1) 1 — Net periodic benefit costs (credits) 5 7 (1) — 6 (1) Settlement losses — 16 — — — 1 Total, including other postretirement losses (gains) $ 5 $ 23 $ (1) $ — $ 6 $ — U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2023 2022 2023 2022 2023 2022 Service cost $ 6 $ 12 $ 1 $ 2 $ 12 $ 19 Interest cost 21 20 11 8 43 26 Expected return on plan assets (17) (22) (13) (9) (48) (50) Recognized net actuarial losses (gains) 5 2 (4) — 9 1 Amortization of prior service cost (credit) — — — (1) 1 — Net periodic benefit costs (credits) 15 12 (5) — 17 (4) Settlement losses 1 29 — — 1 10 Total, including other postretirement losses (gains) $ 16 $ 41 $ (5) $ — $ 18 $ 6

Debt and lines of credit

Debt and lines of credit	9 Months Ended
Debt and lines of credit	Sep. 30, 2023
Debt Disclosure [Abstract]
Debt and lines of credit	Debt and lines of credit Short-term borrowings We maintain a line of credit to provide additional liquidity through bank loans and, if necessary, to support commercial paper borrowings. As of September 30, 2023, the aforementioned line of credit was a variable-rate, revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $1 billion until March 2024. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable Term Secured Overnight Financing Rate (Term SOFR). As of September 30, 2023, our credit facility was undrawn, and we had no commercial paper outstanding. Long-term debt In May 2023, we issued three series of senior unsecured notes for an aggregate principal amount of $1.60 billion, consisting of: • $200 million further issuance of existing 4.60% notes due in 2028; • $200 million further issuance of existing 4.90% notes due in 2033; and • $1.20 billion of 5.05% notes due in 2063. We incurred $7 million of issuance cost and other related costs. The proceeds of the offering were $1.60 billion, net of the original issuance discounts and premiums, which will be used for general corporate purposes. In May 2023, we retired $500 million of maturing debt. In March 2023, we issued two series of senior unsecured notes for an aggregate principal amount of $1.40 billion, consisting of $750 million of 4.90% notes due in 2033 and $650 million of 5.00% notes due in 2053. We incurred $11 million of issuance and other related costs. The proceeds of the offering were $1.40 billion, net of the original issuance discounts, which will be used for general corporate purposes. Long-term debt outstanding is as follows: September 30, December 31, 2023 2022 Notes due 2023 at 2.25% $ — $ 500 Notes due 2024 at 2.625% 300 300 Notes due 2024 at 4.70% 300 300 Notes due 2025 at 1.375% 750 750 Notes due 2026 at 1.125% 500 500 Notes due 2027 at 2.90% 500 500 Notes due 2028 at 4.60% 700 500 Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 750 Notes due 2031 at 1.90% 500 500 Notes due 2032 at 3.65% 400 400 Notes due 2033 at 4.90% 950 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Notes due 2051 at 2.70% 500 500 Notes due 2052 at 4.10% 300 300 Notes due 2053 at 5.00% 650 — Notes due 2063 at 5.05% 1,200 — Total debt 11,300 8,800 Net unamortized discounts, premiums and issuance costs (78) (65) Total debt, including net unamortized discounts, premiums and issuance costs 11,222 8,735 Current portion of long-term debt (300) (500) Long-term debt $ 10,922 $ 8,235

Stockholders' equity

Stockholders' equity	9 Months Ended
Stockholders' equity	Sep. 30, 2023
Equity [Abstract]
Stockholders’ equity	Stockholders’ equity Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2022 $ 1,741 $ 2,951 $ 50,353 $ (40,214) $ (254) 2023 Net income — — 1,708 — — Dividends declared and paid ($1.24 per share) — — (1,125) — — Common stock issued for stock-based awards — (37) — 118 — Stock repurchases — — — (96) — Stock compensation — 104 — — — Other comprehensive income (loss), net of taxes — — — — 2 Dividend equivalents on RSUs — — (6) — — Other — (2) — — — Balance, March 31, 2023 1,741 3,016 50,930 (40,192) (252) Net income — — 1,722 — — Dividends declared and paid ($1.24 per share) — — (1,125) — — Common stock issued for stock-based awards — 36 — 29 — Stock repurchases — — — (77) — Stock compensation — 111 — — — Other comprehensive income (loss), net of taxes — — — — 6 Dividend equivalents on RSUs — — (5) — — Balance, June 30, 2023 1,741 3,163 51,522 (40,240) (246) Net income — — 1,709 — — Dividends declared and paid ($1.24 per share) — — (1,126) — — Common stock issued for stock-based awards — 38 — 35 — Stock repurchases — — — (48) — Stock compensation — 79 — — — Other comprehensive income (loss), net of taxes — — — — 11 Dividend equivalents on RSUs — — (6) — — Other — — (1) — — Balance, September 30, 2023 $ 1,741 $ 3,280 $ 52,098 $ (40,253) $ (235) Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2021 $ 1,741 $ 2,630 $ 45,919 $ (36,800) $ (157) 2022 Net income — — 2,201 — — Dividends declared and paid ($1.15 per share) — — (1,063) — — Common stock issued for stock-based awards — (36) — 93 — Stock repurchases — — — (584) — Stock compensation — 74 — — — Other comprehensive income (loss), net of taxes — — — — 4 Dividend equivalents on RSUs — — (5) — — Other — (1) 1 — — Balance, March 31, 2022 1,741 2,667 47,053 (37,291) (153) Net income — — 2,291 — — Dividends declared and paid ($1.15 per share) — — (1,060) — — Common stock issued for stock-based awards — 31 — 25 — Stock repurchases — — — (1,266) — Stock compensation — 85 — — — Other comprehensive income (loss), net of taxes — — — — (27) Dividend equivalents on RSUs — — (4) — — Balance, June 30, 2022 1,741 2,783 48,280 (38,532) (180) Net income — — 2,295 — — Dividends declared and paid ($1.15 per share) — — (1,051) — — Common stock issued for stock-based awards — 26 — 52 — Stock repurchases — — — (996) — Stock compensation — 68 — — — Other comprehensive income (loss), net of taxes — — — — 26 Dividend equivalents on RSUs — — (5) — — Balance, September 30, 2022 $ 1,741 $ 2,877 $ 49,519 $ (39,476) $ (154)

Contingencies

Contingencies	9 Months Ended
Contingencies	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. General We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our consolidated financial statements.

Supplemental financial informat

Supplemental financial information	9 Months Ended
Supplemental financial information	Sep. 30, 2023
Disclosure Text Block Supplement [Abstract]
Supplemental financial information	Supplemental financial information Restructuring charges/other During the third quarter and first nine months of 2022, restructuring charges/other included $77 million and $209 million, respectively, of preproduction costs at our Lehi, Utah, manufacturing facility, which were included in Other for segment reporting purposes. These costs transitioned primarily to cost of revenue after production began in December 2022. Other long-term assets September 30, December 31, 2023 2022 U.S. CHIPS and Science Act investment tax credit $ 1,153 $ 395 Other 770 740 Total $ 1,923 $ 1,135 Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the third quarters and first nine months of 2023 and 2022. The table below details where these transactions are recorded in our Consolidated Statements of Income. For Three Months Ended For Nine Months Ended Impact to Related Statement of Income Lines September 30, September 30, 2023 2022 2023 2022 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 4 $ 19 $ 12 $ 42 Decrease to OI&E Tax effect (1) (4) (3) (9) Decrease to provision for income taxes Recognized within net income, net of taxes $ 3 $ 15 $ 9 $ 33 Decrease to net income Prior service cost (credit) of defined benefit plans: Amortization of prior service cost (credit) (a) $ 1 $ (1) $ 1 $ (1) Decrease (increase) to OI&E Tax effect — — — — (Decrease) increase to provision for income taxes Recognized within net income, net of taxes $ 1 $ (1) $ 1 $ (1) Decrease (increase) to net income (a) Detailed in Note 5 Stock compensation During the first nine months of 2023, 3 million shares were issued from treasury related to stock compensation. Shares issued from treasury during the third quarter of 2023 were less than 1 million.

Basis of presentation and sig_2

Basis of presentation and significant accounting policies and practices (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December 31, 2022. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2023 and 2022, and the Consolidated Balance Sheet as of September 30, 2023, are not audited but reflect all adjustments that are of a normal recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2022. The results for the three- and nine-month periods are not necessarily indicative of a full year’s results.
Earnings per share (EPS)	Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing non-forfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.
Derivatives and hedging	Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material. We do not use derivatives for speculative or trading purposes.
Fair values of financial instruments	Fair values of financial instrumentsThe fair values of our derivative financial instruments were not material as of September 30, 2023. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments.
Investments measured at fair value	Investments measured at fair value Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. We classify all debt investments as available-for-sale. See Fair-value considerations . Unrealized gains and losses are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and non-marketable investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other non-marketable securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Non-marketable securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on non-marketable investments are recognized in OI&E.
Fair value considerations	Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions. As of September 30, 2023, and December 31, 2022, we had no Level 3 assets or liabilities.
Indemnification guarantees and warranty costs/product liabilities	Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities

Description of business, incl_2

Description of business, including segment and geographic area information (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Information	Segment information For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Revenue: Analog $ 3,353 $ 3,993 $ 9,920 $ 11,801 Embedded Processing 890 821 2,616 2,424 Other 289 427 906 1,133 Total revenue $ 4,532 $ 5,241 $ 13,442 $ 15,358 Operating profit: Analog $ 1,504 $ 2,185 $ 4,541 $ 6,561 Embedded Processing 258 321 813 960 Other (a) 130 172 444 443 Total operating profit $ 1,892 $ 2,678 $ 5,798 $ 7,964 (a) Includes restructuring charges/other
Schedule of Geographic Area Information	Geographic area information The following geographic area information is based on product shipment destination, which does not reflect end demand by geography. For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Revenue: United States $ 630 14 % $ 694 13 % $ 1,900 14 % $ 1,765 11 % China (a) 1,880 41 2,441 47 5,531 41 7,740 50 Rest of Asia 571 13 694 13 1,654 12 1,993 13 Europe, Middle East and Africa 952 21 942 18 2,894 22 2,578 17 Japan 338 7 310 6 976 7 849 6 Rest of world 161 4 160 3 487 4 433 3 Total revenue $ 4,532 100 % $ 5,241 100 % $ 13,442 100 % $ 15,358 100 % (a) Revenue from products shipped into China includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries. The following additional geographic information includes our estimate for revenue based on the location of our end customers’ headquarters, providing a better representation of the geographic profile for where critical decisions are made. For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Revenue: United States $ 1,541 34 % $ 1,782 34 % $ 4,391 33 % $ 5,058 33 % China 813 18 1,143 22 2,561 19 3,758 24 Rest of Asia 434 10 534 10 1,263 10 1,643 11 Europe, Middle East and Africa (a) 1,193 26 1,281 24 3,657 27 3,480 23 Japan 455 10 446 9 1,373 10 1,252 8 Rest of world 96 2 55 1 197 1 167 1 Total revenue $ 4,532 100 % $ 5,241 100 % $ 13,442 100 % $ 15,358 100 % (a) Revenue from end customers headquartered in Germany was 13% and 11% in the third quarters of 2023 and 2022, respectively, and 13% and 10% in the first nine months of 2023 and 2022, respectively.

Basis of presentation and sig_3

Basis of presentation and significant accounting policies and practices (Tables)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings Per Share	Computation and reconciliation of earnings per common share are as follows: For Three Months Ended September 30, 2023 2022 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 1,709 $ 2,295 Income allocated to RSUs (9) (11) Income allocated to common stock $ 1,700 908 $ 1.87 $ 2,284 913 $ 2.50 Dilutive effect of stock compensation plans 8 10 Diluted EPS: Net income $ 1,709 $ 2,295 Income allocated to RSUs (10) (11) Income allocated to common stock $ 1,699 916 $ 1.85 $ 2,284 923 $ 2.47 For Nine Months Ended September 30, 2023 2022 Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 5,139 $ 6,787 Income allocated to RSUs (27) (30) Income allocated to common stock $ 5,112 908 $ 5.63 $ 6,757 919 $ 7.35 Dilutive effect of stock compensation plans 8 10 Diluted EPS: Net income $ 5,139 $ 6,787 Income allocated to RSUs (26) (30) Income allocated to common stock $ 5,113 916 $ 5.58 $ 6,757 929 $ 7.27

Income taxes (Tables)

Income taxes (Tables)	9 Months Ended
Income taxes (Tables)	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	Provision for income taxes is based on the following: For Three Months Ended For Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Taxes calculated using the estimated annual effective tax rate $ 229 $ 391 $ 794 $ 1,147 Discrete tax items (16) (28) (63) (69) Provision for income taxes $ 213 $ 363 $ 731 $ 1,078 Effective tax rate 11 % 14 % 12 % 14 %

Valuation of debt and equity _2

Valuation of debt and equity investments and certain liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Investments	Details of our investments are as follows: September 30, 2023 December 31, 2022 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Money market funds $ 1,141 $ — $ — $ 1,238 $ — $ — Corporate obligations 280 1,519 — 276 1,535 — U.S. government and agency securities 398 4,467 — 680 4,234 — Non-U.S. government and agency securities 100 396 — 149 248 — Mutual funds — — 11 — — 11 Total 1,919 6,382 11 2,343 6,017 11 Other measurement basis: Equity-method investments — — 16 — — 18 Non-marketable investments — — 5 — — 5 Cash on hand 647 — — 707 — — Total $ 2,566 $ 6,382 $ 32 $ 3,050 $ 6,017 $ 34
Assets and Liabilities Accounted for at Fair Value	The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. September 30, 2023 December 31, 2022 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 1,141 $ — $ 1,141 $ 1,238 $ — $ 1,238 Corporate obligations — 1,799 1,799 — 1,811 1,811 U.S. government and agency securities 4,161 704 4,865 4,914 — 4,914 Non-U.S. government and agency securities — 496 496 — 397 397 Mutual funds 11 — 11 11 — 11 Total assets $ 5,313 $ 2,999 $ 8,312 $ 6,163 $ 2,208 $ 8,371 Liabilities: Deferred compensation $ 352 $ — $ 352 $ 326 $ — $ 326 Total liabilities $ 352 $ — $ 352 $ 326 $ — $ 326
Aggregate Maturities of Available-for-sale Debt Investments	The following table presents the aggregate maturities of our available-for-sale debt investments as of September 30, 2023: Fair Value One year or less $ 6,775 One to two years 385

Postretirement benefit plans (T

Postretirement benefit plans (Tables)	9 Months Ended
Postretirement benefit plans (Tables)	Sep. 30, 2023
Retirement Benefits [Abstract]
Expense Related to Defined Benefit and Retiree Health Care Benefit Plans	Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Three Months Ended September 30, 2023 2022 2023 2022 2023 2022 Service cost $ 2 $ 4 $ — $ 1 $ 4 $ 6 Interest cost 7 8 4 3 14 7 Expected return on plan assets (6) (6) (4) (3) (16) (15) Recognized net actuarial losses (gains) 2 1 (1) — 3 1 Amortization of prior service cost (credit) — — — (1) 1 — Net periodic benefit costs (credits) 5 7 (1) — 6 (1) Settlement losses — 16 — — — 1 Total, including other postretirement losses (gains) $ 5 $ 23 $ (1) $ — $ 6 $ — U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit For Nine Months Ended September 30, 2023 2022 2023 2022 2023 2022 Service cost $ 6 $ 12 $ 1 $ 2 $ 12 $ 19 Interest cost 21 20 11 8 43 26 Expected return on plan assets (17) (22) (13) (9) (48) (50) Recognized net actuarial losses (gains) 5 2 (4) — 9 1 Amortization of prior service cost (credit) — — — (1) 1 — Net periodic benefit costs (credits) 15 12 (5) — 17 (4) Settlement losses 1 29 — — 1 10 Total, including other postretirement losses (gains) $ 16 $ 41 $ (5) $ — $ 18 $ 6

Debt and lines of credit (Table

Debt and lines of credit (Tables)	9 Months Ended
Debt and lines of credit (Tables)	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt outstanding is as follows: September 30, December 31, 2023 2022 Notes due 2023 at 2.25% $ — $ 500 Notes due 2024 at 2.625% 300 300 Notes due 2024 at 4.70% 300 300 Notes due 2025 at 1.375% 750 750 Notes due 2026 at 1.125% 500 500 Notes due 2027 at 2.90% 500 500 Notes due 2028 at 4.60% 700 500 Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 750 Notes due 2031 at 1.90% 500 500 Notes due 2032 at 3.65% 400 400 Notes due 2033 at 4.90% 950 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Notes due 2051 at 2.70% 500 500 Notes due 2052 at 4.10% 300 300 Notes due 2053 at 5.00% 650 — Notes due 2063 at 5.05% 1,200 — Total debt 11,300 8,800 Net unamortized discounts, premiums and issuance costs (78) (65) Total debt, including net unamortized discounts, premiums and issuance costs 11,222 8,735 Current portion of long-term debt (300) (500) Long-term debt $ 10,922 $ 8,235

Stockholders' equity (Tables)

Stockholders' equity (Tables)	9 Months Ended
Stockholders' equity (Tables)	Sep. 30, 2023
Equity [Abstract]
Schedule of Changes in Stockholders' Equity	Changes in equity are as follows: Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2022 $ 1,741 $ 2,951 $ 50,353 $ (40,214) $ (254) 2023 Net income — — 1,708 — — Dividends declared and paid ($1.24 per share) — — (1,125) — — Common stock issued for stock-based awards — (37) — 118 — Stock repurchases — — — (96) — Stock compensation — 104 — — — Other comprehensive income (loss), net of taxes — — — — 2 Dividend equivalents on RSUs — — (6) — — Other — (2) — — — Balance, March 31, 2023 1,741 3,016 50,930 (40,192) (252) Net income — — 1,722 — — Dividends declared and paid ($1.24 per share) — — (1,125) — — Common stock issued for stock-based awards — 36 — 29 — Stock repurchases — — — (77) — Stock compensation — 111 — — — Other comprehensive income (loss), net of taxes — — — — 6 Dividend equivalents on RSUs — — (5) — — Balance, June 30, 2023 1,741 3,163 51,522 (40,240) (246) Net income — — 1,709 — — Dividends declared and paid ($1.24 per share) — — (1,126) — — Common stock issued for stock-based awards — 38 — 35 — Stock repurchases — — — (48) — Stock compensation — 79 — — — Other comprehensive income (loss), net of taxes — — — — 11 Dividend equivalents on RSUs — — (6) — — Other — — (1) — — Balance, September 30, 2023 $ 1,741 $ 3,280 $ 52,098 $ (40,253) $ (235) Common Stock Paid-in Capital Retained Earnings Treasury Common Stock AOCI Balance, December 31, 2021 $ 1,741 $ 2,630 $ 45,919 $ (36,800) $ (157) 2022 Net income — — 2,201 — — Dividends declared and paid ($1.15 per share) — — (1,063) — — Common stock issued for stock-based awards — (36) — 93 — Stock repurchases — — — (584) — Stock compensation — 74 — — — Other comprehensive income (loss), net of taxes — — — — 4 Dividend equivalents on RSUs — — (5) — — Other — (1) 1 — — Balance, March 31, 2022 1,741 2,667 47,053 (37,291) (153) Net income — — 2,291 — — Dividends declared and paid ($1.15 per share) — — (1,060) — — Common stock issued for stock-based awards — 31 — 25 — Stock repurchases — — — (1,266) — Stock compensation — 85 — — — Other comprehensive income (loss), net of taxes — — — — (27) Dividend equivalents on RSUs — — (4) — — Balance, June 30, 2022 1,741 2,783 48,280 (38,532) (180) Net income — — 2,295 — — Dividends declared and paid ($1.15 per share) — — (1,051) — — Common stock issued for stock-based awards — 26 — 52 — Stock repurchases — — — (996) — Stock compensation — 68 — — — Other comprehensive income (loss), net of taxes — — — — 26 Dividend equivalents on RSUs — — (5) — — Balance, September 30, 2022 $ 1,741 $ 2,877 $ 49,519 $ (39,476) $ (154)

Supplemental financial inform_2

Supplemental financial information (Tables)	9 Months Ended
Supplemental financial information (Tables)	Sep. 30, 2023
Disclosure Text Block Supplement [Abstract]
Schedule of Other Long-Term Assets	Other long-term assets September 30, December 31, 2023 2022 U.S. CHIPS and Science Act investment tax credit $ 1,153 $ 395 Other 770 740 Total $ 1,923 $ 1,135
Amounts Reclassified Out of AOCI to Net Income, Net of Taxes	The table below details where these transactions are recorded in our Consolidated Statements of Income. For Three Months Ended For Nine Months Ended Impact to Related Statement of Income Lines September 30, September 30, 2023 2022 2023 2022 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 4 $ 19 $ 12 $ 42 Decrease to OI&E Tax effect (1) (4) (3) (9) Decrease to provision for income taxes Recognized within net income, net of taxes $ 3 $ 15 $ 9 $ 33 Decrease to net income Prior service cost (credit) of defined benefit plans: Amortization of prior service cost (credit) (a) $ 1 $ (1) $ 1 $ (1) Decrease (increase) to OI&E Tax effect — — — — (Decrease) increase to provision for income taxes Recognized within net income, net of taxes $ 1 $ (1) $ 1 $ (1) Decrease (increase) to net income (a) Detailed in Note 5

Description of business, incl_3

Description of business, including segment and geographic area information - Additional Information (Details) - reportable_segment	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Number of reportable segments			2
Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Concentration risk, percentage	100%	100%	100%	100%

Description of business, incl_4

Description of business, including segment and geographic area information - Segment Information (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Total revenue		$ 4,532	$ 5,241	$ 13,442	$ 15,358
Total operating profit		1,892	2,678	5,798	7,964
Analog
Segment Reporting Information [Line Items]
Total revenue		3,353	3,993	9,920	11,801
Total operating profit		1,504	2,185	4,541	6,561
Embedded Processing
Segment Reporting Information [Line Items]
Total revenue		890	821	2,616	2,424
Total operating profit		258	321	813	960
Other
Segment Reporting Information [Line Items]
Total revenue		289	427	906	1,133
Total operating profit	[1]	$ 130	$ 172	$ 444	$ 443

[1]Includes restructuring charges/other

Description of business, incl_5

Description of business, including segment and geographic area information - Geographic Area Information (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Total revenue		$ 4,532	$ 5,241	$ 13,442	$ 15,358
Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue		$ 4,532	$ 5,241	$ 13,442	$ 15,358
Concentration risk, percentage		100%	100%	100%	100%
Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue		$ 4,532	$ 5,241	$ 13,442	$ 15,358
Concentration risk, percentage		100%	100%	100%	100%
United States \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue		$ 630	$ 694	$ 1,900	$ 1,765
Concentration risk, percentage		14%	13%	14%	11%
United States \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue		$ 1,541	$ 1,782	$ 4,391	$ 5,058
Concentration risk, percentage		34%	34%	33%	33%
China \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue	[1]	$ 1,880	$ 2,441	$ 5,531	$ 7,740
Concentration risk, percentage	[1]	41%	47%	41%	50%
China \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue		$ 813	$ 1,143	$ 2,561	$ 3,758
Concentration risk, percentage		18%	22%	19%	24%
Rest of Asia \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue		$ 571	$ 694	$ 1,654	$ 1,993
Concentration risk, percentage		13%	13%	12%	13%
Rest of Asia \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue		$ 434	$ 534	$ 1,263	$ 1,643
Concentration risk, percentage		10%	10%	10%	11%
Europe, Middle East and Africa \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue		$ 952	$ 942	$ 2,894	$ 2,578
Concentration risk, percentage		21%	18%	22%	17%
Europe, Middle East and Africa \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue	[2]	$ 1,193	$ 1,281	$ 3,657	$ 3,480
Concentration risk, percentage	[2]	26%	24%	27%	23%
Japan \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue		$ 338	$ 310	$ 976	$ 849
Concentration risk, percentage		7%	6%	7%	6%
Japan \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue		$ 455	$ 446	$ 1,373	$ 1,252
Concentration risk, percentage		10%	9%	10%	8%
Rest of world \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Shipment Destination
Segment Reporting Information [Line Items]
Total revenue		$ 161	$ 160	$ 487	$ 433
Concentration risk, percentage		4%	3%	4%	3%
Rest of world \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Total revenue		$ 96	$ 55	$ 197	$ 167
Concentration risk, percentage		2%	1%	1%	1%
Germany \| Revenue from Contract with Customer, Product and Service Benchmark \| Geographic Concentration Risk, Customers' Headquarters
Segment Reporting Information [Line Items]
Concentration risk, percentage		13%	11%	13%	10%

[1]Revenue from products shipped into China includes shipments to customers that manufacture in China and then export end products to their customers around the world, as well as distributors that transship inventory through China to service other countries.[2]Revenue from end customers headquartered in Germany was 13% and 11% in the third quarters of 2023 and 2022, respectively, and 13% and 10% in the first nine months of 2023 and 2022, respectively.

Basis of presentation and sig_4

Basis of presentation and significant accounting policies and practices - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Basic EPS:
Net income	$ 1,709	$ 2,295	$ 5,139	$ 6,787
Income allocated to RSUs	(9)	(11)	(27)	(30)
Income allocated to common stock	$ 1,700	$ 2,284	$ 5,112	$ 6,757
Weighted average number of shares outstanding, basic (in shares)	908	913	908	919
Basic (in dollars per share)	$ 1.87	$ 2.50	$ 5.63	$ 7.35
Dilutive effect of stock compensation plans (in shares)	8	10	8	10
Diluted EPS:
Net income	$ 1,709	$ 2,295	$ 5,139	$ 6,787
Income allocated to RSUs	(10)	(11)	(26)	(30)
Income allocated to common stock for diluted EPS	$ 1,699	$ 2,284	$ 5,113	$ 6,757
Weighted average number of shares outstanding, diluted (in shares)	916	923	916	929
Diluted (in dollars per share)	$ 1.85	$ 2.47	$ 5.58	$ 7.27

Basis of presentation and sig_5

Basis of presentation and significant accounting policies and practices - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Antidilutive securities excluded from computation of earnings per share, Amount (in shares)	9	6	9	5
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, carrying value	$ 11,222		$ 11,222		$ 8,735
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, estimated fair value	$ 9,820		$ 9,820

Income taxes - Provision for In

Income taxes - Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Taxes calculated using the estimated annual effective tax rate	$ 229	$ 391	$ 794	$ 1,147
Discrete tax items	(16)	(28)	(63)	(69)
Provision for income taxes	$ 213	$ 363	$ 731	$ 1,078
Effective tax rate	11%	14%	12%	14%

Income taxes - Additional Infor

Income taxes - Additional Information (Details)	9 Months Ended
Income taxes - Additional Information (Details)	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Statutory corporate tax rate	21%

Valuation of debt and equity _3

Valuation of debt and equity investments and certain liabilities - Investments at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	$ 2,566	$ 3,050
Short-term investments	6,382	6,017
Long-Term Investments	32	34
Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,919	2,343
Short-term investments	6,382	6,017
Long-Term Investments	11	11
Money market funds \| Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,141	1,238
Short-term investments	0	0
Long-Term Investments	0	0
Corporate obligations \| Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	280	276
Short-term investments	1,519	1,535
Long-Term Investments	0	0
U.S. government and agency securities \| Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	398	680
Short-term investments	4,467	4,234
Long-Term Investments	0	0
Non-U.S. government and agency securities \| Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	100	149
Short-term investments	396	248
Long-Term Investments	0	0
Mutual funds \| Measured at fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	11	11
Equity-method investments \| Other measurement basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	16	18
Non-marketable investments \| Other measurement basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	5	5
Cash on hand \| Other measurement basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	647	707
Short-term investments	0	0
Long-Term Investments	$ 0	$ 0

Valuation of debt and equity _4

Valuation of debt and equity investments and certain liabilities - Aggregate Liabilities of Our Available-for-Sale Debt Investments (Details) $ in Millions	Sep. 30, 2023 USD ($)
Fair Value Disclosures [Abstract]
One year or less	$ 6,775
One to two years	$ 385

Valuation of debt and equity _5

Valuation of debt and equity investments and certain liabilities - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Credit losses related to available-for-sale investments			$ 0	$ 0
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments	$ 2,890,000,000	$ 3,030,000,000	9,980,000,000	$ 10,010,000,000
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities, fair value	0		0		$ 0
Assets, fair value	$ 0		$ 0		$ 0

Valuation of debt and equity _6

Valuation of debt and equity investments and certain liabilities - Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Recurring - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 8,312	$ 8,371
Total liabilities fair value	352	326
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	352	326
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	5,313	6,163
Total liabilities fair value	352	326
Level 1 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	352	326
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,999	2,208
Total liabilities fair value	0	0
Level 2 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,141	1,238
Money market funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,141	1,238
Money market funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,799	1,811
Corporate obligations \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Corporate obligations \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,799	1,811
U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	4,865	4,914
U.S. government and agency securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	4,161	4,914
U.S. government and agency securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	704	0
Non-U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	496	397
Non-U.S. government and agency securities \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Non-U.S. government and agency securities \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	496	397
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	11	11
Mutual funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	11	11
Mutual funds \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 0	$ 0

Postretirement benefit plans -

Postretirement benefit plans - Expense Related to Defined Benefit and Retiree Health Care Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
U.S. \| Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 2	$ 4	$ 6	$ 12
Interest cost	7	8	21	20
Expected return on plan assets	(6)	(6)	(17)	(22)
Recognized net actuarial losses (gains)	2	1	5	2
Amortization of prior service cost (credit)	0	0	0	0
Net periodic benefit costs (credits)	5	7	15	12
Settlement losses	0	16	1	29
Total, including other postretirement losses (gains)	5	23	16	41
U.S. \| Retiree health care plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	1	1	2
Interest cost	4	3	11	8
Expected return on plan assets	(4)	(3)	(13)	(9)
Recognized net actuarial losses (gains)	(1)	0	(4)	0
Amortization of prior service cost (credit)	0	(1)	0	(1)
Net periodic benefit costs (credits)	(1)	0	(5)	0
Settlement losses	0	0	0	0
Total, including other postretirement losses (gains)	(1)	0	(5)	0
Non-U.S. \| Defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	4	6	12	19
Interest cost	14	7	43	26
Expected return on plan assets	(16)	(15)	(48)	(50)
Recognized net actuarial losses (gains)	3	1	9	1
Amortization of prior service cost (credit)	1	0	1	0
Net periodic benefit costs (credits)	6	(1)	17	(4)
Settlement losses	0	1	1	10
Total, including other postretirement losses (gains)	$ 6	$ 0	$ 18	$ 6

Debt and lines of credit - Addi

Debt and lines of credit - Additional Information (Details)	1 Months Ended		3 Months Ended		9 Months Ended
Debt and lines of credit - Additional Information (Details)	May 31, 2023 USD ($) series	Mar. 31, 2023 USD ($) series	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Debt Instrument [Line Items]
Commercial paper			$ 0		$ 0
Proceeds from issuance of long-term debt					3,000,000,000	$ 695,000,000
Repayment of debt					500,000,000	500,000,000
Interest and debt expense			$ 98,000,000	$ 53,000,000	$ 255,000,000	$ 154,000,000
Notes due 2028 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)			4.60%		4.60%
Notes due 2033 at 4.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)			4.90%		4.90%
Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)			5.05%		5.05%
Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)			2.25%		2.25%
Repayment of debt	$ 500,000,000
Notes due 2053 at 5.00%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)			5%		5%
Senior unsecured notes
Debt Instrument [Line Items]
Number of series of debt issued \| series	3	2
Principal amount	$ 1,600,000,000	$ 1,400,000,000
Debt issuance costs	7,000,000	11,000,000
Proceeds from issuance of long-term debt	1,600,000,000	1,400,000,000
Senior unsecured notes \| Notes due 2028 at 4.60%
Debt Instrument [Line Items]
Principal amount	$ 200,000,000
Long-term debt stated interest rate (in percentage)	4.60%
Senior unsecured notes \| Notes due 2033 at 4.90%
Debt Instrument [Line Items]
Principal amount	$ 200,000,000	$ 750,000,000
Long-term debt stated interest rate (in percentage)	4.90%	4.90%
Senior unsecured notes \| Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Principal amount	$ 1,200,000,000
Long-term debt stated interest rate (in percentage)	5.05%
Senior unsecured notes \| Notes due 2053 at 5.00%
Debt Instrument [Line Items]
Principal amount		$ 650,000,000
Long-term debt stated interest rate (in percentage)		5%
Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity			$ 1,000,000,000		$ 1,000,000,000

Debt and lines of credit - Sche

Debt and lines of credit - Schedule of Long-term Debt Outstanding (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total debt	$ 11,300	$ 8,800
Net unamortized discounts, premiums and issuance costs	(78)	(65)
Total debt, including net unamortized discounts, premiums and issuance costs	11,222	8,735
Current portion of long-term debt	(300)	(500)
Long-term debt	$ 10,922	8,235
Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 0	500
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.625%
Total debt	$ 300	300
Notes due 2024 at 4.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.70%
Total debt	$ 300	300
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.375%
Total debt	$ 750	750
Notes due 2026 at 1.125%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.125%
Total debt	$ 500	500
Notes due 2027 at 2.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.90%
Total debt	$ 500	500
Notes due 2028 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.60%
Total debt	$ 700	500
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 750	750
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 750	750
Notes due 2031 at 1.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.90%
Total debt	$ 500	500
Notes due 2032 at 3.65%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.65%
Total debt	$ 400	400
Notes due 2033 at 4.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.90%
Total debt	$ 950	0
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.875%
Total debt	$ 750	750
Notes due 2048 at 4.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.15%
Total debt	$ 1,500	1,500
Notes due 2051 at 2.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.70%
Total debt	$ 500	500
Notes due 2052 at 4.10%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.10%
Total debt	$ 300	300
Notes due 2053 at 5.00%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	5%
Total debt	$ 650	0
Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	5.05%
Total debt	$ 1,200	$ 0

Stockholders' equity - Schedule

Stockholders' equity - Schedule of Changes in Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning			$ 14,577				$ 14,577
Net income	$ 1,709			$ 2,295			5,139	$ 6,787
Other comprehensive income (loss), net of taxes	11			26			19	3
Balance, ending	16,631						16,631
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	1,741	$ 1,741	1,741	1,741	$ 1,741	$ 1,741	1,741	1,741
Balance, ending	1,741	1,741	1,741	1,741	1,741	1,741	1,741	1,741
Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	3,163	3,016	2,951	2,783	2,667	2,630	2,951	2,630
Common stock issued for stock-based awards	38	36	(37)	26	31	(36)
Stock compensation	79	111	104	68	85	74
Other	0		(2)			(1)
Balance, ending	3,280	3,163	3,016	2,877	2,783	2,667	3,280	2,877
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	51,522	50,930	50,353	48,280	47,053	45,919	50,353	45,919
Net income	1,709	1,722	1,708	2,295	2,291	2,201
Dividends declared and paid	(1,126)	(1,125)	(1,125)	(1,051)	(1,060)	(1,063)
Dividend equivalents on RSUs	(6)	(5)	(6)	(5)	(4)	(5)
Other	(1)					1
Balance, ending	52,098	51,522	50,930	49,519	48,280	47,053	52,098	49,519
Treasury Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(40,240)	(40,192)	(40,214)	(38,532)	(37,291)	(36,800)	(40,214)	(36,800)
Common stock issued for stock-based awards	35	29	118	52	25	93
Stock repurchases	(48)	(77)	(96)	(996)	(1,266)	(584)
Balance, ending	(40,253)	(40,240)	(40,192)	(39,476)	(38,532)	(37,291)	(40,253)	(39,476)
AOCI
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning	(246)	(252)	(254)	(180)	(153)	(157)	(254)	(157)
Other comprehensive income (loss), net of taxes	11	6	2	26	(27)	4
Balance, ending	$ (235)	$ (246)	$ (252)	$ (154)	$ (180)	$ (153)	$ (235)	$ (154)

Stockholders' equity - Addition

Stockholders' equity - Additional Information (Details) - $ / shares	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 1.24	$ 1.24	$ 1.24	$ 1.15	$ 1.15	$ 1.15
Cash dividends paid per common share (in dollars per share)	$ 1.24	$ 1.24	$ 1.24	$ 1.15	$ 1.15	$ 1.15

Supplemental financial inform_3

Supplemental financial information - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Asset Acquisition [Line Items]
Treasury shares issued related to stock compensation (less than for third quarter of 2023) (in shares)	1		3
Lehi, Utah \| Other
Asset Acquisition [Line Items]
Restructuring charges/other		$ 77		$ 209

Supplemental financial inform_4

Supplemental financial information - Other Long-Term Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
U.S. CHIPS and Science Act investment tax credit	$ 1,153	$ 395
Other	770	740
Other long-term assets	$ 1,923	$ 1,135

Supplemental financial inform_5

Supplemental financial information - Amounts Reclassified out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)		$ 128	$ 33	$ 327	$ 55
Provision for income taxes		(213)	(363)	(731)	(1,078)
Net income		1,709	2,295	5,139	6,787
Reclassification out of Accumulated Other Comprehensive Income \| Net actuarial losses of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	4	19	12	42
Provision for income taxes		(1)	(4)	(3)	(9)
Net income		3	15	9	33
Reclassification out of Accumulated Other Comprehensive Income \| Prior service credit of defined benefit plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	1	(1)	1	(1)
Provision for income taxes		0	0	0	0
Net income		$ 1	$ (1)	$ 1	$ (1)

[1]Detailed in Note 5